GenNext Technologies
Revolutionizing protein higher order structural analysis
16 employees · est. 2018 · Half Moon Bay, United States
Vernalis
We develop and apply fragment and structure-based methods to solve problems in drug discovery
253 employees · est. 1997 · Cambridge, United Kingdom
Vernalis is the older company (2018 vs 1997); Vernalis is the larger of the two.
Side-by-Side Comparison
| Metric | GenNext Technologies | Vernalis |
|---|---|---|
| Founded | ||
| Founded | 2018 | 1997 older |
| Headquarters | ||
| Headquarters | Half Moon Bay, United States | Cambridge, United Kingdom |
| Employees | ||
| Employees | 16 | 253 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Non Equity Assistance | Series Unknown |
| Total Funding | ||
| Total Funding | $7.00M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 2 | 1 |
| Services | ||
| Services | Not tracked yet | Drug Discovery Collaboration, Protein Production, Hit Identification and Validation, Lead Optimization, Biophysics and Structural Biology, Chemical Series Evolution |
| Target Customers | ||
| Target Customers | Not tracked yet | Pharmaceutical Companies, Biotech Firms, Research Institutions, Drug Discovery Teams |
| Taxonomy | ||
| Taxonomy | Structural Biology, Biopharmaceutical, Instrumentation, Pharmaceutical, Biopharmaceutical Development, Therapeutic Efficacy, Safety, Protein Analysis, Formulation, Structural Analysis, Interactions, Revolutionary Technology, Innovation | Fragment-based Drug Discovery, Structure-based Methods, Oncology Drug Discovery, Neurodegeneration Targets, Anti-infectives, Inflammation Drug Discovery, Structural Biology, Biophysics, Medicinal Chemistry, Molecular Modelling, Protein-protein Interactions, Development Of Clinical Candidates, Kinases And ATPases, GPCRs, Shared-risk Research Collaborations |
| Website | ||
| Website | gnxtech.com | vernalis.com |
About GenNext Technologies
GenNext Technologies is a biopharma and biotechnology startup with a mission to revolutionize protein higher order structural analysis. Since its establishment in 2016, the company has been dedicated to making structural biology more accessible by offering a range of products and services aimed at p...
About Vernalis
Vernalis, founded in 1997, is a UK-based company operating at the forefront of the Biotechnology and Pharmaceutical industries. With a commitment to advancing drug discovery, their slogan encapsulates their mission: "We develop and apply fragment and structure-based methods to solve problems in drug...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at GenNext Technologies and Vernalis — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at GenNext Technologies and Vernalis — by email.
Frequently Asked Questions
Compare GenNext Technologies with someone else
Start typing a company name or domain.